1 - (4-chlorophenyl) - 4 - (4-morpholinyl) - 2,5 - dihydro - 1 - 2 - 2 - 1, or a physiologically acceptable sla. compound formulation chimiqu: 1 - (4-chlorophenyl) 4 - morpholino imidazolin - 2 - 1

摘要

The present invention relates to the use of substituted dihydroimidazolones, particularly [1-(4-Chlorophenyl)-4-(4-morpholinyl)-2,5-dihydro-1H-imidazol-2-one] (AWD 131-138) or a physiologically acceptable salt thereof for the treatment of epilepsy and behavioural abnormalities in dogs.